Published in PLoS Med on February 16, 2010
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05
CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res (2011) 9.62
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol (2012) 2.85
The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med (2013) 2.80
Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One (2014) 2.75
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med (2015) 2.72
PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med (2012) 2.31
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother (2010) 2.27
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med (2010) 2.24
The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep (2013) 2.22
The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep (2013) 2.11
Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement†‡. Hum Reprod (2014) 2.06
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med (2016) 1.94
Reporting guidelines for survey research: an analysis of published guidance and reporting practices. PLoS Med (2011) 1.87
Quality of reporting in systematic reviews of adverse events: systematic review. BMJ (2014) 1.81
Using the time and motion method to study clinical work processes and workflow: methodological inconsistencies and a call for standardized research. J Am Med Inform Assoc (2011) 1.66
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res (2012) 1.62
The National Institutes of Health and guidance for reporting preclinical research. BMC Med (2015) 1.48
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med (2013) 1.44
ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol (2015) 1.44
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med (2011) 1.42
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review. BMJ (2014) 1.41
A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol (2016) 1.36
A scoping review of rapid review methods. BMC Med (2015) 1.26
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol (2015) 1.25
Effectiveness of IV cannulation skills laboratory training and its transfer into clinical practice: a randomized, controlled trial. PLoS One (2012) 1.25
Setting the RECORD straight: developing a guideline for the REporting of studies Conducted using Observational Routinely collected Data. Clin Epidemiol (2013) 1.19
Financial Conflicts of Interest Checklist 2010 for clinical research studies. Open Med (2010) 1.19
The CARE guidelines: consensus-based clinical case reporting guideline development. Dtsch Arztebl Int (2013) 1.17
Developing a guideline for clinical trial protocol content: Delphi consensus survey. Trials (2012) 1.17
Guidelines for randomized clinical trial protocol content: a systematic review. Syst Rev (2012) 1.15
Acceptance checklist for clinical effectiveness pilot trials: a systematic approach. BMC Med Res Methodol (2013) 1.14
Protocol for CONSORT-SPI: an extension for social and psychological interventions. Implement Sci (2013) 1.13
Empty reviews: a description and consideration of Cochrane systematic reviews with no included studies. PLoS One (2012) 1.11
COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials (2015) 1.10
A systematic scoping review of adherence to reporting guidelines in health care literature. J Multidiscip Healthc (2013) 1.07
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med (2015) 1.07
Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA). BMC Med (2015) 1.05
Reporting quality of social and psychological intervention trials: a systematic review of reporting guidelines and trial publications. PLoS One (2013) 1.05
Methodological quality and reporting of generalized linear mixed models in clinical medicine (2000-2012): a systematic review. PLoS One (2014) 1.04
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines. PLoS One (2015) 1.02
Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2). Trials (2015) 0.99
Developing standards for reporting implementation studies of complex interventions (StaRI): a systematic review and e-Delphi. Implement Sci (2015) 0.97
Developing a reporting guideline for social and psychological intervention trials. Trials (2013) 0.96
Protocol for development of the guideline for reporting evidence based practice educational interventions and teaching (GREET) statement. BMC Med Educ (2013) 0.96
Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut): An Extension of the STROBE Statement. PLoS Med (2016) 0.96
Reporting guidelines for modelling studies. BMC Med Res Methodol (2012) 0.95
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial (2014) 0.94
A Delphi survey to determine how educational interventions for evidence-based practice should be reported: stage 2 of the development of a reporting guideline. BMC Med Educ (2014) 0.94
The SQUIRE Guidelines: an evaluation from the field, 5 years post release. BMJ Qual Saf (2015) 0.93
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Eur J Health Econ (2013) 0.93
Core Outcome Set-STAndards for Reporting: The COS-STAR Statement. PLoS Med (2016) 0.91
A methodological systematic review of what's wrong with meta-ethnography reporting. BMC Med Res Methodol (2014) 0.90
Guidelines for reporting embedded recruitment trials. Trials (2016) 0.90
The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ (2016) 0.90
Findings from a novel approach to publication guideline revision: user road testing of a draft version of SQUIRE 2.0. BMJ Qual Saf (2015) 0.89
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Cost Eff Resour Alloc (2013) 0.88
A tool to make reporting checklists work. BMC Med (2015) 0.88
Workshop on a CONSORT statement for Ayuveda. J Ayurveda Integr Med (2010) 0.87
A systematic review of how studies describe educational interventions for evidence-based practice: stage 1 of the development of a reporting guideline. BMC Med Educ (2014) 0.87
The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci (2015) 0.86
Behavior change interventions to improve the health of racial and ethnic minority populations: a tool kit of adaptation approaches. Milbank Q (2013) 0.86
Standardised method for reporting exercise programmes: protocol for a modified Delphi study. BMJ Open (2014) 0.85
STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Epidemiol (2011) 0.84
Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol. Syst Rev (2012) 0.84
A checklist to improve reporting of group-based behaviour-change interventions. BMC Public Health (2015) 0.84
Strengthening the Reporting of Observational Studies in Epidemiology - nutritional epidemiology (STROBE-nut): An extension of the STROBE statement. Nutr Bull (2016) 0.84
SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica (2015) 0.83
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation (2015) 0.83
Developing a reporting guideline for social and psychological intervention trials. Am J Public Health (2013) 0.82
Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease. BMC Pediatr (2015) 0.82
The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review. Syst Rev (2014) 0.81
The reporting of observational clinical functional magnetic resonance imaging studies: a systematic review. PLoS One (2014) 0.81
A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES). Neurotoxicol Teratol (2011) 0.80
A Systematic Review of Reporting Tools Applicable to Sexual and Reproductive Health Programmes: Step 1 in Developing Programme Reporting Standards. PLoS One (2015) 0.80
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. Pharmacoeconomics (2015) 0.80
Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. Trials (2015) 0.80
Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp). PLoS Med (2017) 0.80
Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol (2015) 0.79
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet (2011) 0.79
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Cancer (2015) 0.79
Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials. Pilot Feasibility Stud (2016) 0.79
A systematic review of the main factors that determine agility in sport using structural equation modeling. J Hum Kinet (2016) 0.79
Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology - Veterinary (STROBE-Vet) Statement. J Vet Intern Med (2016) 0.78
Protocol-developing meta-ethnography reporting guidelines (eMERGe). BMC Med Res Methodol (2015) 0.78
A systematic review of surface electromyography analyses of the bench press movement task. PLoS One (2017) 0.78
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. PLoS One (2011) 0.78
The development and evaluation of a five-language multi-perspective standardised measure: clinical decision-making involvement and satisfaction (CDIS). BMC Health Serv Res (2014) 0.78
Health systems guidance appraisal-a critical interpretive synthesis. Implement Sci (2016) 0.78
Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET). BMC Med Educ (2016) 0.77
A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). Pharmacoeconomics (2015) 0.77
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials. Implement Sci (2015) 0.77
Developing a Reporting Guideline for Social and Psychological Intervention Trials. Res Soc Work Pract (2013) 0.77
Reporting the characteristics of the policy context for population-level alcohol interventions: a proposed 'Transparent Reporting of Alcohol Intervention ContExts' (TRAICE) checklist. Drug Alcohol Rev (2014) 0.77
Studying the consumption and health outcomes of fiscal interventions (taxes and subsidies) on food and beverages in countries of different income classifications; a systematic review. BMC Public Health (2015) 0.77
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet (2004) 18.69
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Consensus development methods, and their use in clinical guideline development. Health Technol Assess (1998) 11.56
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem (2003) 8.13
What is missing from descriptions of treatment in trials and reviews? BMJ (2008) 7.33
Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet (2004) 7.18
Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34
How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med (2007) 5.86
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med (2003) 4.68
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ (2005) 3.65
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
The quality of diagnostic accuracy studies since the STARD statement: has it improved? Neurology (2006) 3.63
Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med (2008) 3.22
EQUATOR: reporting guidelines for health research. Lancet (2008) 3.15
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS One (2008) 2.38
Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Ann Intern Med (2008) 2.37
Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model. J Altern Complement Med (2008) 1.97
A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol (2005) 1.74
An international survey indicated that unpublished systematic reviews exist. J Clin Epidemiol (2009) 1.70
Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol (2007) 1.57
Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol (2008) 1.48
Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). Nurs Outlook (2008) 1.38
An assessment of the quality of randomised controlled trials conducted in China. Trials (2008) 1.35
Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. JAMA (1998) 1.32
Reporting research results: a moral obligation for all researchers. Can J Anaesth (2007) 1.32
[Developing guidelines for reporting healthcare research: scientific rationale and procedures]. Med Clin (Barc) (2005) 1.26
Consort statement on the reporting standards of clinical trials. MRC uses checklist similar to CONSORT's. BMJ (1997) 1.17
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47
Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61
Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55
Reporting recommendations for tumor marker prognostic studies. J Clin Oncol (2005) 6.31
The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ (2010) 5.70
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58
No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57
Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat (2007) 5.52
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ (2009) 5.45
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
Bias and causal associations in observational research. Lancet (2002) 5.36
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ (2005) 5.36
The design of simulation studies in medical statistics. Stat Med (2006) 5.30
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Ghost authorship in industry-initiated randomised trials. PLoS Med (2007) 4.95
Refining clinical diagnosis with likelihood ratios. Lancet (2005) 4.84
Quantification of the completeness of follow-up. Lancet (2002) 4.77
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA (2012) 4.73
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Prognosis and prognostic research: what, why, and how? BMJ (2009) 4.46
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ (2010) 4.46
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat (2006) 4.42
Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ (2009) 4.38
Prognosis and prognostic research: Developing a prognostic model. BMJ (2009) 4.38
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med (2015) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med (2007) 4.29
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
An overview of clinical research: the lay of the land. Lancet (2002) 4.04
Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J (2002) 3.96